CAPSTEAD MORTGAGE CORP
SC 13G/A, 1996-02-12
REAL ESTATE INVESTMENT TRUSTS
Previous: PUTNAM INVESTMENTS INC, SC 13G/A, 1996-02-12
Next: HEALTH CARE REIT INC /DE/, S-3/A, 1996-02-12




                SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549

                           SCHEDULE 13G

            Under the Securities Exchange Act of 1934
                        (Amendment No. 5)*

                    Capstead Mortgage Corporation                
                         (Name of Issuer)

              Common Stock, par value $0.01 per share            
                  (Title of Class and Securities)

                             14067E 10 0                         
              (CUSIP Number of Class of Securities)

No fee is required with respect to this filing.

*The remainder of this cover page shall be filled out for
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page
shall be deemed to be "filed" for the purpose of Section 18 of
the Securities Exchange Act of 1934 ("Act") or otherwise subject
to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).


                           SCHEDULE 13G

CUSIP No. 14067E 10 0
                                                                 

(1)  NAMES OF REPORTING PERSONS
     S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

Howard Hughes Medical Institute                                  

I.R.S. Indemnification No.:  59-0735717                          

(2)  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
                                                       
                                                     (a)  ( )
                                                           
                                                     (b)  ( )
Not applicable                                                   

(3)  SEC USE ONLY


(4)  CITIZENSHIP OR PLACE OF ORGANIZATION 

Delaware                                                         

                         (5)  SOLE VOTING POWER

                              900,000
    NUMBER                                                    
      OF                 (6)  SHARED VOTING POWER
    SHARES
 BENEFICIALLY                 0                               
   OWNED BY              (7)  SOLE DISPOSITIVE POWER
     EACH
  REPORTING                   900,000
 PERSON WITH
                                                     
                         (8)  SHARED DISPOSITIVE POWER

                              0                                  


(9)  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

900,000
                                                                 

(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
     SHARES*                                             (  )

(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

3.8%

(12) TYPE OF REPORTING PERSON*

EP                                                               


Item 1.

     (a)  Name of Issuer:  Capstead Mortgage Corporation ("CMC").
     (b)  Address of Issuer's Principal Executive Offices:  2711
          North Haskell, Dallas, Texas 75204

Item 2.

     (a)  Name of Person Filing:  Howard Hughes Medical
          Institute.
     (b)  Address of Principal Business Office:  4000 Jones
          Bridge Road, Chevy Chase, Maryland 20815-6789.
     (c)  Citizenship:  Delaware corporation.
     (d)  Title of Class of Securities:  Common Stock, par value
          $0.01 per share, of CMC.
     (e)  CUSIP Number:  14067E 10 0.

Item 3.   If this statement is being filed pursuant to Rule 13d-
1(b) or 13d-2(b), check whether the person filing is:  

[X] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund.

Item 4.   Ownership.

     (a)  Amount beneficially Owned:  900,000
     (b)  Percent of Class:  3.8%
     (c)  Number of shares as to which such person has:
          (i)   Sole power to vote or to direct the vote: 
               900,000
          (ii)  Shared power to vote or to direct the vote:  0.
          (iii) Sole power to dispose or to direct the
                disposition:  900,000
          (iv)  Shared power to dispose or to direct the
                disposition:  0.

Item 5.   Ownership of Five Percent or Less of a Class:  (X)

Item 6.   Ownership of More than Five Percent on Behalf of
          Another Person:  N/A.

Item 7.   Identification and Classification of the Subsidiary
          Which Acquired the Security Being Reported on By the
          Parent Holding Company:  N/A.

Item 8.   Identification and Classification of Members of the
          Group:  N/A.

Item 9.   Notice of Dissolution of Group:  N/A.


Item 10.  Certification.

     By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purposes or effect.

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.

Dated:  February   , 1996

HOWARD HUGHES MEDICAL INSTITUTE

By:  ________________________
     Craig A. Alexander, Esq.
     Deputy General Counsel




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission